During the past weeks two important recommendations were published from the US Preventive Services Task Forse (USPSTF) on the screening for colorectal cancer and syphilis. Let’s have a look at them, alongside other news that our members shared in the Among Doctors community:
- The US Preventive Services Task Force (USPSTF) published its recommendations on screening for colorectal cancer
The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years (A recommendation). - Screening for Syphilis: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Screening HIV-positive men or MSM for syphilis every 3 months is associated with improved syphilis detection. Treponemal or nontreponemal tests are accurate screening tests but require confirmation. - Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial
Maternal exercise may be a preventative tool for hypertension and excessive GWG, and may control offspring size at birth while reducing comorbidities related to chronic disease risk. - Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage
The treatment of participants with intracerebral hemorrhage to achieve a target systolic blood pressure of 110 to 139 mm Hg did not result in a lower rate of death or disability than standard reduction to a target of 140 to 179 mm Hg. - Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
Receipt of industry-sponsored meals was associated with an increased rate of prescribing the brand-name medication that was being promoted. The findings represent an association, not a cause-and-effect relationship. - Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
Current evidence does not support increasing the dose of ICS as part of a self initiated action plan to treat exacerbations in adults and children with mild to moderate asthma. Increased ICS dose is not associated with a statistically significant reduction in the odds of requiring rescue oral corticosteroids for the exacerbation, or of having adverse events, compared with a stable ICS dose.
Do you wish to comment on these news or share your own? Join Among Doctors here and start exploring the physician-exclusive social network right away!
